RCOG, BMS, FSRH statement on HRT and contraceptive supply
The RCOG, BMS and FSRH have issued a press release regarding the HRT and contraceptive shortages.
Joint RCOG & BMS statement in response to the Lancet study on HRT use and breast cancer risk
A study published in The Lancet shows the risk of breast cancer with hormone replacement therapy (HRT) in relation to the type and timing of hormonal intake.
BMS response to Lancet paper on the link between different forms of HRT and breast cancer incidence
A meta-analysis published in the Lancet this week by the Collaborative Group on Hormonal Factors in Breast Cancer reported on the risk of breast cancer with HRT in relation to the type and timing of hormonal intake.
Joint RCOG / BMS / FSRH position on ongoing HRT shortages
The Royal College of Obstetricians and Gynaecologists (RCOG), the British Menopause Society (BMS) and the Faculty of Sexual and Reproductive Health care (FSRH) are receiving multiple queries from women who are unable to access their hormone replacement therapy (HRT) products due to ongoing manufacturing and supply issues.
Tonight – BBC1, 10.45pm: ‘Kirsty Wark: The Menopause and Me’
This documentary features Dr Heather Currie, Chair of the British Menopause Society (BMS). The British Menopause Society and the Royal College of Obstetricians and Gynaecologists (RCOG) have issued a statement ahead of the screening.
Hormone Replacement Therapy can lower risk of early death in women, a new study suggests
Results have been reported from a study of more than 4,200 women who received a coronary calcium scan at Cedars-Sinai Medical Center between 1998 and 2012. A coronary calcium scan is a CT scan that measures the amount of calcium in the heart's arteries.
HRT and quality of sleep
Many women experience disturbed sleep as a menopausal symptom, which can have a significant effect on mood and energy levels and cause distress, and lead to increased risk of heart disease, diabetes and obesity.
Use of Hormone Therapy if you carry the BRCA gene
The effect on breast cancer risk for women who carry the BRCA gene and the use of HRT after removal of ovaries for risk-reducing surgery.
British Menopause Society/ Royal College of Obstetricians and Gynaecologists response to Breast Cancer Now Generations Study on HRT use and breast cancer risk
The British Menopause Society and Royal College of Obstetricians and Gynaecologists issue a response to the findings that the effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies.
Breast Cancer Now study finds the effect of combined HRT on breast cancer risk is likely to have been underestimated
The effect of combined hormone replacement therapy (HRT) in increasing a woman’s risk of breast cancer is likely to have been underestimated by a number of previous studies, according to a new prospective study published in the British Journal of Cancer.